Special Issue "Therapeutic Potential of Marine Polyphenols"
Deadline for manuscript submissions: 30 April 2024 | Viewed by 5937
Interests: phloroglucinol oligomers; phlorotrannins; eckols; pharmcology; anti-neurodegeneration; anti-aging; chemical synthesis
Interests: natural product isolation; characterization; bioactivity; Alzheimer drug screening
Polyphenols, which are widely found in plants and well-known for their various physiological effects, exist in a variety of molecular classes. Among them, “marine polyphenols”, which are produced as second metabolites of marine algae, have recently gained attention from the health-care industry. In general, marine polyphenols can be chemically defined as oligomers of phloroglucinol. During the past two decades, scientists have accumulated a large body of in vitro and in vivo evidence that motivates their therapeutic applications in many areas of intractable diseases, including neurodegenerative diseases, cancers, and viral diseases, as well as many other chronic degenerative diseases. Furthermore, the structural nature of marine polyphenols provides unlimited possibility of chemical modifications that may be useful in drug development. In order to exploit such potential and develop them as competitive drugs, research efforts focused on pharmacologically and pharmaceutically relevant information are required.
The aim of this Special Issue is to gather new information regarding the in-depth understanding of pharmacologically and pharmaceutically relevant aspects of marine polyphenols. Scientists who work in the study of marine polyphenols focusing on physicochemical characterizations, synthetic derivatives, bioactivities in general, molecular targets, mechanisms of action, and pharmacology in general are highly welcome to contribute research articles and reviews.
Dr. Hyeon-Cheol Shin
Dr. Bong Ho Lee
Dr. Hye Jeong Hwang
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- phloroglucinol oligomer
- physicochemical characterization
- synthetic derivatives
- molecular target
- mechanism of action